Skip to main content

Table 2 Summary of characteristics of the public microarray datasets compared with IST patients

From: Glyceraldehyde-3-phosphate dehydrogenase gene over expression correlates with poor prognosis in non small cell lung cancer patients

Dataset (year) Patient number Age median (min-max) Stage I-II-III NSCLS subtype 5-years cumulative survival (95% CI) Microarray platform
IST (2012) 82 69 (47–82) 44-15-23 ADK SCC other 0.54 (.44-.66) RQ-PCR
[24] Shedden et al. (2008) all patients 442 65 (33–87) 276-96-69 ADK 0.55 (.50-.60) Affymetrix U133a
[24] Shedden et al. (2008) adjuvant-naïve 330 65 (33–87) 230-60-40 ADK 0.60 (.55-.66) Affyimetrix U133a
[25] Lee et al. (2008) 138 62 (13–82) n.a. ADK SCC 0.50 (.42-.59) Affymetrix U133plus2
[26] Tomida et al. (2009) 117 61 (32–84) 79-13-25 ADK 0.66 (.58-.75) Agilent 44k
[27] Roepman et al. (2009) 172 54 (22–79) 117-55-0 ADK SCC other 0.65 (.57-.74) Agilent 44k*
[28] Okayama et al. (2012) 226 61 (30–76) 168-58-0 ADK 0.84 (.79-.89) Affymetrix U133plus2
[29] Botling at al. (2013) 196 65 (39–84) 130-35-31 ADK SCC 0.42 (.35-.49) Affymetrix U133plus2
  1. *custom annotation provided.